JPRN-UMIN000017011招募中4 期
Special Drug Use Surveillance of LIXIANA Tablet- Long-term use in patients with non-valvular atrial fibrillation
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who meet the following
- •requirements when starting to
- •receive LIXIANA (at the time of
- •enrollment for [4]) will be
- •considered for admission to the
- •[1]Patients with NVAF who have just started to receive LIXIANA for the first time to prevent ischemic stroke and systemic embolism
- •[2] Patients who are to start
- •treatment with LIXIANA during the
- •period of contract (as per the signed
- •contract between the institution and
- •the sponsor) and during the
- •enrollment period
- •[3]Patients who will be available for long-term follow-up
- •[4]Patients who have given written informed consent to the study
排除标准
- 未提供
研究者
相似试验
招募中
4 期
Special Drug Use Surveillance of LIXIANA Tablet- Long-term use in patients with venous thromboembolismJPRN-UMIN000016387DAIICHI SANKYO COMPANY, LIMITED1,500
招募中
不适用
Special Drug Use Surveillance of Alecensa Capsules in Pediatric Patients- Recurrent or refractory ALK fusion gene-positive anaplastic large cell lymphomaRecurrent or refractory ALK fusion gene-positive anaplastic large cell lymphomaJPRN-UMIN000039803Chugai Pharmaceutical Co. Ltd.10
进行中（未招募）
不适用
Protocol Number; CLCZ696B1401Chronic Heart FailureJPRN-jRCT2031200432Sugimoto Toshiya660
招募中
Unknown
Post-marketing Surveillance Protocol Number;CLCZ696A1402HypertensionJPRN-jRCT2031230283Sugigmoto Toshiya1,000
未知
Unknown
Special drug use surveillance of Leuplin PRO for Injection Kit 22.5 mg for Prostate cancerProstate cancerJPRN-jRCT1080223158TAKEDA PHARMACEUTICAL COMPANY LTD.333